ARTSaVIT completes venture financing

On Jan. 5, cancer apoptosis company ARTSaVIT Ltd. (Yavne, Israel) raised $6.3 million in a series A round co-led by Arkin Bio Ventures and Pontifax. Merck Ventures, Carmel Innovation and Carmel-Haifa...